Tag: stroke drug
Basking Biosciences doses first patients in part B of RAISE trial...
Basking Biosciences has announced the first patients have been dosed in part B of its Phase 2 RAISE trial of BB-031, an investigational ribonucleic...
Revalesio receives US FDA fast-track designation for RNS60 in acute ischaemic...
Revalesio announced recently that the US Food and Drug Administration (FDA) has granted a fast-track designation to RNS60—the company’s lead investigational therapy—for the treatment...
Merck assumes clinical development and commercialisation of stroke drug ApTOLL
AptaTargets has announced an agreement with German pharmaceutical giant Merck—signed in October 2024—for the clinical development and commercialisation of ApTOLL, a Toll-like receptor 4...
Remedy announces upcoming presentation of “groundbreaking” CHARM study data at ISC...
Remedy Pharmaceuticals has announced that three speaker presentations reporting efficacy data from both the Phase 2 GAMES-RP and Phase 3 CHARM studies on its...
TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the...
